Rheumatoid Arthritis Clinical Trials in Philadelphia

Showing 1761-1780 of 3,347 trials

Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis

NCT03373877

This is a multicenter 2-part, Phase 1b study designed to assess the safety, tolerability, pharmacokinetics (PK) and preliminary efficacy of PU-H71 in subjects taking concomitant ruxolitinib. The first part (Dose Escalation) will employ a standard 3+3 dose escalation design to determine Maximum Tolerated Dose (MTD). The second part of the study (Dose Confirmation) will confirm the recommended Phase 2 dose (RP2D) in an expanded population.

MyelofibrosisPrimary MyelofibrosisPost-polycythemia Vera Myelofibrosis+1 more

Samus Therapeutics, Inc.4 participantsStarted May 2018

New Haven, Connecticut, United States • New Orleans, Louisiana, United States • Ann Arbor, Michigan, United States +7 more locations

UNKNOWN< 1 mile

TruGraf® Long-term Clinical Outcomes Study

NCT04491552

This is a prospective, multi-center, observational study. Subjects will have OmniGraf™ (TruGraf® and TRAC™) testing at study enrollment and thereafter every 3 months. In addition subjects will have OmniGraf™ (TruGraf® and TRAC™) testing at any time there is a clinical suspicion of acute rejection. Data collection for the primary objective extends over a 2-year period.

Kidney Transplant Rejection

Transplant Genomics, Inc.2,000 participantsStarted Sep 2020

Tucson, Arizona, United States • Fresno, California, United States • La Jolla, California, United States +33 more locations

Evaluation of Ruxolitinib in Combination With PU-H71 for Treatment of Myelofibrosis

TruGraf® Long-term Clinical Outcomes Study

Rheumatoid Arthritis Trials in Other Cities

Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA)

Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy

Stimulant Medication Effects on Auditory Sensitivity in Teens With ADHD

A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Clinical Performance of Two Commercial, Daily Disposable Contact Lenses

MIMICS-3D-USA Registry Study

Study of the Efficacy and Safety of Ublituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

The LEADLESS II IDE Study for the Aveir VR Leadless Pacemaker System

Investigation of Sulindac (HLX-0201) and Gaboxadol (HLX-0206) in Male Fragile X Syndrome Patients Aged 13-40

Reduced Intensity Conditioning for Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (BMT CTN 1204)

A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study

A Multiple Dose Study of Repeat Intravitreal Injections of GEM103 in Neovascular Age-related Macular Degeneration

A Prospective, Epidemiological Study to Assess the Disease Burden of Respiratory Syncytial Virus Associated, Suspected Lower Respiratory Tract Infections in Newborns, From 0 to 2 Years of Age and Risk of Development of Wheeze and Asthma From 0 to 6 Years of Age

Diagnostic Accuracy Of Forced Oscillation Technique To Detect Lung Function Anomalies

Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury

A Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Other Conditions in Philadelphia